Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 Journal Article


Authors: Garon, E. B.; Hellmann, M. D.; Costa, E. C.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; Gubens, M. A.; Ramalingam, S. S.; Felip, E.; Scalzo, C.; Jensen, E.; Kush, D. A.; Hui, R.
Article Title: Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 18
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-06-01
Language: English
ACCESSION: WOS:000489109800013
DOI: 10.1200/JCO.2019.37.18_suppl.LBA9015
PROVIDER: wos
Notes: Meeting Abstract -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL -- S -- Source: Wos
Altmetric Score